ACHIEVING COMPREHENSIVE DISEASE CONTROL IN LONG-STANDING OR EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE VERSUS METHOTREXATE ALONE

被引：0
|
作者：
Keystone, E. C. [1 ]
Breedveld, F. C. [2 ]
van der Heijde, D. [2 ]
van Vollenhoven, R. F. [3 ]
Florentinus, S. [4 ]
Faccin, F. [5 ]
Liu, S. [5 ]
Kupper, H. [6 ]
Kavanaugh, A. F. [7 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Leiden Univ Med Ctr, Leiden, Netherlands
[3] Karolinska Inst, Stockholm, Sweden
[4] AbbVie, Rungis, France
[5] AbbVie Inc, N Chicago, IL USA
[6] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [21] Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-α blocker plus methotrexate versus methotrexate or leflunomide alone
    Wisiowska, Margaret
    Jakubicz, Danuta
    RHEUMATOLOGY INTERNATIONAL, 2007, 27 (07) : 641 - 647
  • [22] Radiographic inhibition of structural damage sustained in patients with long-standing rheumatoid arthritis following 2 years of treatment with adalimumab (Humira®) plus methotrexate
    Keystone, EC
    Kavanaugh, AF
    Sharp, JT
    Spencer-Green, G
    Perez, JL
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 277 - 277
  • [23] DIACEREIN IN COMBINATION WITH METHOTREXATE VERSUS METHOTREXATE ALONE IN THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Louthrenoo, W.
    Nilganuwong, S.
    Nanagara, R.
    Siripaitoon, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 262 - 262
  • [24] Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis
    Miyata, Masayuki
    Hirabayashi, Yasuhiko
    Munakata, Yasuhiko
    Urata, Yukitomo
    Saito, Koichi
    Okuno, Hiro- shi
    Yoshida, Masaaki
    Kodera, Takao
    Watanabe, Ryu
    Miyamoto, Seiya
    Ishii, Tomonori
    Nakazawa, Shigeshi
    Takemori, Hiromitsu
    Ando, Takanobu
    Kanno, Takashi
    Komagamine, Masataka
    Kato, Ichiro
    Takahashi, Yuichi
    Komatsuda, Atsushi
    Endo, Kojiro
    Murai, Chihiro
    Takakubo, Yuya
    Miura, Takao
    Sato, Yukio
    Ichikawa, Kazunobu
    Konta, Tsuneo
    Chiba, Noriyuki
    Muryoi, Tai
    Kobayashi, Hiroko
    Fujii, Hiroshi
    Sekiguchi, Yukio
    Hatakeyama, Akira
    Ogura, Ken
    Sakuraba, Hirotake
    Asano, To- moyuki
    Kanazawa, Hiroshi
    Suzuki, Eiji
    Takasaki, Satoshi
    Asakura, Kenichi
    Suzuki, Yoko
    Takagi, Michiaki
    Nakayama, Takahiro
    Watanabe, Hiroshi
    Miura, Keiki
    Mori, Yu
    FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2024, 70 (01) : 55 - 55
  • [25] Response to pneumococcal vaccine in patients with, early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone
    Visvanathan, Sudha
    Keenan, Gregory F.
    Baker, Daniel G.
    Levinson, Arnold I.
    Wagner, Carrie L.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (05) : 952 - 957
  • [26] Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
    Taylor, Peter C.
    Alten, Rieke
    Gracia, Jose Maria Alvaro
    Kaneko, Yuko
    Walls, Chad
    Quebe, Amanda
    Jia, Bochao
    Bello, Natalia
    Terres, Jorge Ross
    Fleischmann, Roy
    RMD OPEN, 2022, 8 (01):
  • [27] The ARMADA trial:: Sustained efficacy and long-term safety of adalimumab (humira®) plus methotrexate over 3 years in patients with long-standing rheumatoid arthritis
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Spencer-Green, GT
    Mydler, T
    Segurado, OG
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 295 - 295
  • [28] METHOTREXATE REDUCES IMMUNOGENICITY IN ADALIMUMAB TREATED RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 101 - 102
  • [29] TREATMENT OUTCOMES BASED ON METHOTREXATE DOSE RANGE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ETANERCEPT PLUS METHOTREXATE VERSUS METHOTREXATE ALONE
    Fleischmann, R.
    Koenig, A.
    Pederson, R.
    Ferdousi, T.
    Bananis, E.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 13 - 13
  • [30] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    van Vollenhoven, R
    Sharp, J
    Perez, JL
    Spencer-Green, GT
    ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
12345